Cargando…
Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis
Hepatocellular carcinoma (HCC) is a common malignancy worldwide. Alpha-fetoprotein (AFP) is still the only serum biomarker widely used in clinical settings. However, approximately 40% of HCC patients exhibit normal AFP levels, including very early HCC and AFP-negative HCC; for these patients, serum...
Autores principales: | Wang, Ting, Huang, Xue-ying, Zheng, Su-jun, Liu, Ye-ying, Chen, Si-si, Ren, Feng, Lu, Jun, Duan, Zhong-ping, Liu, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555665/ https://www.ncbi.nlm.nih.gov/pubmed/34722278 http://dx.doi.org/10.3389/fonc.2021.733680 |
Ejemplares similares
-
Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy
por: Mahmud, Joyeta, et al.
Publicado: (2023) -
3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages
por: Sun, Gangqi, et al.
Publicado: (2022) -
Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer
por: Hatzipetros, Ioannis, et al.
Publicado: (2013) -
Over-expression of 14-3-3zeta is an early event in oral cancer
por: Matta, Ajay, et al.
Publicado: (2007) -
Thermomechanical Properties of Zeta (Ag(3)In) Phase
por: Liu, Xunda, et al.
Publicado: (2023)